These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26248005)

  • 41. In Silico Prediction of Chemically Induced Mutagenicity: How to Use QSAR Models and Interpret Their Results.
    Mombelli E; Raitano G; Benfenati E
    Methods Mol Biol; 2016; 1425():87-105. PubMed ID: 27311463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated strategy for mutagenicity prediction applied to food contact chemicals.
    Manganelli S; Schilter B; Benfenati E; Manganaro A; Lo Piparo E
    ALTEX; 2018; 35(2):169-178. PubMed ID: 28922667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?
    Amberg A; Anger LT; Bercu J; Bower D; Cross KP; Custer L; Harvey JS; Hasselgren C; Honma M; Johnson C; Jolly R; Kenyon MO; Kruhlak NL; Leavitt P; Quigley DP; Miller S; Snodin D; Stavitskaya L; Teasdale A; Trejo-Martin A; White AT; Wichard J; Myatt GJ
    Mutagenesis; 2019 Mar; 34(1):67-82. PubMed ID: 30189015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A local QSAR model based on the stability of nitrenium ions to support the ICH M7 expert review on the mutagenicity of primary aromatic amines.
    Furukawa A; Ono S; Yamada K; Torimoto N; Asayama M; Muto S
    Genes Environ; 2022 Mar; 44(1):10. PubMed ID: 35313995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (Q)SARs: gatekeepers against risk on chemicals?
    Hulzebos EM; Posthumus R
    SAR QSAR Environ Res; 2003 Aug; 14(4):285-316. PubMed ID: 14506871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Applicability of in silico genotoxicity models on food and feed ingredients.
    Vuorinen A; Bellion P; Beilstein P
    Regul Toxicol Pharmacol; 2017 Nov; 90():277-288. PubMed ID: 28964846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro genotoxicity testing-Can the performance be enhanced?
    Corvi R; Madia F
    Food Chem Toxicol; 2017 Aug; 106(Pt B):600-608. PubMed ID: 27554597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In Silico Approaches in Predictive Genetic Toxicology.
    Sinha M; Dhawan A; Parthasarathi R
    Methods Mol Biol; 2019; 2031():351-373. PubMed ID: 31473971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategy proposal using QSAR models to approach mutagenicity assessment of non intentionally added substances in recycled plastic resins.
    Djelassi I; Lancia P; Thuillier I; Ginestar J; Fioravanzo E; Baleydier A
    Food Chem Toxicol; 2024 May; 187():114597. PubMed ID: 38492856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines.
    Doak SH; Manshian B; Jenkins GJ; Singh N
    Mutat Res; 2012 Jun; 745(1-2):104-11. PubMed ID: 21971291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-Hydroxypyridine-N-oxide (HOPO): Equivocal in the ames assay.
    Dobo KL; Cheung JR; Gunther WC; Kenyon MO
    Environ Mol Mutagen; 2018 May; 59(4):312-321. PubMed ID: 29481708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Silico Prediction of Chemically Induced Mutagenicity: A Weight of Evidence Approach Integrating Information from QSAR Models and Read-Across Predictions.
    Mombelli E; Raitano G; Benfenati E
    Methods Mol Biol; 2022; 2425():149-183. PubMed ID: 35188632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutagenic potential and structural alerts of phytotoxins.
    Bassan A; Pavan M; Lo Piparo E
    Food Chem Toxicol; 2023 Mar; 173():113562. PubMed ID: 36563927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of mutagenicity, carcinogenicity, developmental toxicity, and skin sensitisation with Caesar program for a set of conazoles.
    Bolčič-Tavčar M; Vračko M
    Arh Hig Rada Toksikol; 2012 Sep; 63(3):283-92. PubMed ID: 23152378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutagenicity in a Molecule: Identification of Core Structural Features of Mutagenicity Using a Scaffold Analysis.
    Hsu KH; Su BH; Tu YS; Lin OA; Tseng YJ
    PLoS One; 2016; 11(2):e0148900. PubMed ID: 26863515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting Ames Mutagenicity Using Conformal Prediction in the Ames/QSAR International Challenge Project.
    Norinder U; Ahlberg E; Carlsson L
    Mutagenesis; 2019 Mar; 34(1):33-40. PubMed ID: 30541036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotoxicity assessment of peptide/protein-related biotherapeutics: points to consider before testing.
    Thybaud V; Kasper P; Sobol Z; Elhajouji A; Fellows M; Guerard M; Lynch AM; Sutter A; Tanir JY
    Mutagenesis; 2016 Jul; 31(4):375-84. PubMed ID: 27000792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DeepAmes: A deep learning-powered Ames test predictive model with potential for regulatory application.
    Li T; Liu Z; Thakkar S; Roberts R; Tong W
    Regul Toxicol Pharmacol; 2023 Oct; 144():105486. PubMed ID: 37633327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantification and In Silico Toxicity Assessment of Tazarotene and its Impurities for a Quality and Safe Drug Product Development.
    Nagulakonda NNM; Ananthula RS; Krishnamurthy T; Rao MRP; Rao GN
    J Chromatogr Sci; 2019 Aug; 57(7):625-635. PubMed ID: 31037297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strategies in genotoxicology: Acceptance of innovative scientific methods in a regulatory context and from an industrial perspective.
    Steiblen G; Benthem JV; Johnson G
    Mutat Res Genet Toxicol Environ Mutagen; 2020 May; 853():503171. PubMed ID: 32522346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.